Metrics to compare | FERO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFEROPeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.3x | 16.5x | −0.3x | |
PEG Ratio | 0.57 | 0.83 | 0.00 | |
Price/Book | 1.1x | 2.9x | 2.6x | |
Price / LTM Sales | 0.6x | 1.5x | 3.0x | |
Upside (Analyst Target) | - | 35.6% | 57.9% | |
Fair Value Upside | Unlock | 18.6% | 7.6% | Unlock |
Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Sri Lanka, Afghanistan, Myanmar, the Philippines, Uzbekistan, Kyrgyzstan, Kenya, and internationally. The company provides products for various categories, including antibiotics, cardiology weight loss, oncology, hepatology, gastroenterology, urology, hair growth, cough syrups and lozenges, pain relief, anticoagulants, anti-inflammatory, hypertension, antiallergics, antianxiety/antidepressants, nephrology, antiemetics, antivirals, antiepileptics, dermatology and skincare, iron preparations, antifungals, diabetes, rheumatology, and vitamins. It also provides medical devices in the areas of cardiology, gastrointestinal endoscopy, oncology, peripheral vascular disease, urology, women’s health applications, neurology, EEG diagnostics, ECG systems, and critical care and patient monitoring systems. In addition, the company exports its products. Ferozsons Laboratories Limited was founded in 1894 and is based in Lahore, Pakistan.